Navigation Links
Positive Clinical Data on CC-10004 Confirms Potential as Novel Oral,Approach to Treating Inflammatory Diseases

Celgene to Advance Clinical and Regulatory Development of Oral Anti-Inflammatory Franchise

SUMMIT, N.J., May 22, 2007 /PRNewswire-FirstCall/ -- Celgene Corporation announced its plans to advance the development of leading oral anti-inflammatory candidates across a broad range of inflammatory diseases. CC-10004 (apremilast), an oral TNF antagonist and anti-inflammatory agent has demonstrated significant activity and an excellent side effect profile in a placebo controlled proof-of-mechanism trial in psoriasis.

The multicenter, randomized, double blind, placebo-controlled Phase II study achieved the primary endpoint after 12 weeks of treatment with 24% of patients receiving CC-10004 twice daily achieving a PASI-75 score compared to 10% of those receiving placebo. The Psoriasis Area and Severity Index (PASI) is a standard measurement of response utilized to assess improvement in patients with moderate to severe psoriasis. In addition, 57% of patients receiving CC-10004 twice daily achieved a PASI-50 compared to 23% of those receiving placebo. Most importantly, patients receiving CC-10004 continued to improve over time.

"The data from the Phase II study in patients with moderate-to-severe psoriasis are clinically and statistically significant compared with placebo. In addition, patients continued to improve throughout the 12 week treatment regimen with an oral therapy that has a good side effect profile addressing an unmet medical need," said Alice Gottlieb, M.D., Ph.D., Dermatologist in Chief and Chair, Department of Dermatology of Tufts-New England Medical Center. "The PASI-90 response of 14% for CC-10004 is comparable to Enbrel dosed at 25 mg twice weekly."

Based on these results, Celgene is accelerating clinical and regulatory strategies for CC-10004 in psoriasis, psoriatic arthritis, rheumatoid arthritis and other inflammatory diseases. The Company is also initiating development plans to a
'"/>




Page: 1 2 3 4

Related medicine technology :

1. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
2. Positive Aggrastat Results Featured in the Journal of the American College of Cardiology
3. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
4. Protox Announces Positive Clinical Data from Prostate Cancer Study
5. AM-Pharma Announces Positive Results of Phase IIa Clinical Trial with Alkaline Phosphatase For Ulcerative Colitis
6. Cougar Biotechnology Announces Presentation of Positive CB7630 Clinical Data at ESMO Conference
7. TransPharma Medical Announces Positive Results of Phase I Clinical Trials for Transdermal Delivery of hPTH (1-34) for Osteoporosis Treatment
8. Positive ZIO-201 Interim Phase II Sarcoma Data Presented at European Society for Medical Oncology
9. Cosmo Pharmaceuticals Reports Positive Preliminary Phase II/III Data with Rifamycin MMX in Infectious Diarrhea
10. Portola Pharmaceuticals Announces Positive Phase II EXPERT Results and Additional Oral and Poster Presentations at the XXI Congress of the International Society on Thrombosis and Haemostasis (ISTH)
11. Chi-Med Announces Positive Phase II Proof-of-Concept Data for HMPL-004 in Ulcerative Colitis
Post Your Comments:
(Date:3/6/2015)... N.J. , March 6, 2015  Palatin Technologies, Inc. ... at the 27 th Annual ROTH Conference on Wednesday, ... will be held at the Ritz Carlton Laguna Niguel in ... Carl Spana , Ph.D., President and Chief Executive Officer ... and development programs. About Palatin Technologies, ...
(Date:3/6/2015)...  Pomerantz LLP is investigating claims on behalf of ... (NASDAQ: CNAT ).  Such investors are advised ... rswilloughby@pomlaw.com or 888-476-6529, ext. 237. The ... and/or directors have violated Sections 10(b) and 20(a) of ... On March 5, 2015, the Company abruptly announced in ...
(Date:3/6/2015)... , March 6, 2015  The onset of puberty ... as well as clumsier, and thus more inclined toward a ... during puberty, while the body,s center of gravity is altered. ... hands often grow more quickly than the rest of the ... of height in single year. And while these sudden changes ...
Breaking Medicine Technology:SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Conatus Pharmaceuticals Inc. - CNAT 2Puberty can result in variety of athletic injuries 2
... PLAINFIELD, N.J., Dec. 22 PTC Therapeutics, Inc. (PTC) ... round was led by The Column Group - a new investor ... joined by current investors Credit Suisse First Boston, HBM BioVentures, Novo ... with the Delphi investment, general partner Deepa Pakianathan, Ph.D. will join ...
... Minn., Dec. 21 Envoy Medical, a Minnesota corporation, has ... the Esteem®. On December 18th, an Advisory Panel ... the Esteem®. , Patrick Spearman, Envoy Medical,s Chief ... for all sensorineural hearing loss sufferers. Envoy has been ...
Cached Medicine Technology:PTC Therapeutics Closes $50 Million Financing 2
(Date:3/6/2015)... 2015 Today, the California Healthcare Institute ... M.D., Ph.D., Director of the National Institutes of Health ... for a roundtable discussion regarding the vibrancy of the ... President Obama's Precision Medicine Initiative. , Joint Statement from ... Dean of the School of Medicine, UC San Diego; ...
(Date:3/6/2015)... Mediaplanet today announces distribution of its ... seeks to educate, encourage, and inspire women to take ... health and their health care rights. With gynecological cancer ... more pertinent to prioritize well-woman exams and stand up ... of “Women’s Health” is distributed within this weekend’s edition ...
(Date:3/6/2015)... York, NY (PRWEB) March 06, 2015 Dr. ... has been seeking a ban on the use of power ... a recurrence of the cancer that prompted the launch of ... earlier this week that the 41-year-old mother of six ... the bony part in her spine. Dr. Reed had been ...
(Date:3/6/2015)... 06, 2015 As healthcare providers ... and content from disparate systems, they are using ... and increase efficiency. Enterprise content management ... with core IT solutions, including electronic medical records ... IT applications. , The following organizations have ...
(Date:3/6/2015)... March 06, 2015 Sanjay Gupta, ... deliver a keynote address at ATA 2015, the ... and Trade Show and world’s largest telemedicine, telehealth ... neurosurgeon, delivers medical correspondence for several of CNN’s ... and documentaries including his DuPont Award winning WEED ...
Breaking Medicine News(10 mins):Health News:California’s Life Sciences Sector Hosts NIH Director in San Diego 2Health News:California’s Life Sciences Sector Hosts NIH Director in San Diego 3Health News:The Well-Woman: Encouraging Regular Screenings and Advocating for Women’s Health Rights with Mediaplanet’s “Women’s Health” Campaign 2Health News:Power Morcellator News: Bernstein Liebhard LLP Comments on Report that Physician Working to Ban Uterine Morcellation Has Cancer Recurrence 2Health News:Power Morcellator News: Bernstein Liebhard LLP Comments on Report that Physician Working to Ban Uterine Morcellation Has Cancer Recurrence 3Health News:Power Morcellator News: Bernstein Liebhard LLP Comments on Report that Physician Working to Ban Uterine Morcellation Has Cancer Recurrence 4Health News:Healthcare Providers Select OnBase by Hyland to Improve Patient Care and Streamline Administrative Departments 2Health News:Healthcare Providers Select OnBase by Hyland to Improve Patient Care and Streamline Administrative Departments 3Health News:CNN’s Dr. Sanjay Gupta Among Headliners at American Telemedicine Association 2015 Annual Meeting 2
... In international study has found that people in their ... five years longer than those with hypertension or high ... had normal blood pressure developed heart disease later in ... has been published in the current issue of Hypertension: ...
... research had showed that patients who are depressed and ... having another heart attack is lessened considerably with the ... often treat clinical depression, also known as unipolar depression, ... SSRIs are a group of drugs that can increase ...
... have less back pain from osteoporosis related// curving of the ... special exercises. ,In a study presented by the researchers ... back support device can not only decrease the back pain ... women who had suffered the disease. ,Elderly population remains ...
... by the ‘Delhi High Court’ on Tuesday Justice Vikramjit Sen passed ... 12 year old for the wrong treatment administered by Dr ... the next few days how much compensation was the hospital ready ... indicated that the operation for total hip replacement and fixation of ...
... from Children's Hospital Boston suggests that a urine test ... anomalies. The study also raises the possibility of treating ... of the journal - Pediatrics, has published an article ... found in about 10% of newly born infants and ...
... who have television in their bedroom may score less in ... TV in their rooms. In a new study by the ... Stanford University researchers have reported that the home environment, especially ... their ability to affect the performance of children in school. ...
Cached Medicine News:Health News:Normal Blood Pressure Could Add Over 5 Years To Your Life 2Health News:Simple Urine Test Can Help To Monitor Disfiguring Birthmarks, 2
Clinical micro clamps by Acland. Matte finish. It provides impressive security in use, both against slippage and against leakage due to controlled closing force and working grip surface....
Clinical micro clamps by Acland. Matte finish. It provides impressive security in use, both against slippage and against leakage due to controlled closing force and working grip surface....
Extremely fine straight....
Curved delicate 5 mm blades....
Medicine Products: